Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.

@article{Piao2018RegulationOP,
  title={Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.},
  author={Lianhua Piao and Kyoko Fujioka and Makoto Nakakido and Ryuji Hamamoto},
  journal={Frontiers in bioscience},
  year={2018},
  volume={23},
  pages={
          13-26
        }
}
The poly(ADP-ribose) polymerases (PARPs) catalyze poly(ADP-ribosyl)ation, a post-translational modification of proteins. This  consists of the attachment of mono- or poly-adenosine diphosphate (ADP)-ribose units from nicotinamide adenine dinucleotide (NAD+) to specific polar residues of target proteins. PARP1 is the most abundant and best-characterized member of the family of PARP enzymes. PARP1 plays key roles in DNA repair, as well as a wide variety of cellular processes, including… 

Figures from this paper

ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control

TLDR
An update on the function of a large set of enzyme writers, the readers that are recruited by the modified targets, and the erasers that reverse the modification to the original amino acid residue, removing the covalent bonds formed is presented.

ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.

TLDR
The properties of the different enzymes associated with ADP-ribosylation and the consequences of this PTM on substrates are discussed and the different domains that interpret either mono- or poly-ADP- ribosylations and the implications for cellular processes are described.

The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond

TLDR
The molecular mechanisms and signaling pathways that PARP1 is associated with in the regulation of pathogenesis and how their signaling downstream effecters can provide more potential therapeutic targets for the treatment of the related diseases in the future is discussed.

Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose)

TLDR
An overview on the current knowledge of the biochemical and physiological significance of poly(ADP-ribosyl)transferases, carried out by poly-ARTs, PARPs, which play essential roles in (patho-) physiology, as well as cancer therapy is provided.

[Poly adenosine diphosphate-ribosylation and neurodegenerative diseases].

  • Yi WangYunbi Lu
  • Biology, Chemistry
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
  • 2020
TLDR
The morbidity of neurodegenerative diseases are increased in recent years, however, the treatment is limited and to find new PARP inhibitors with more specific effects and specific pharmacokinetic characteristics will be the new direction for the treatment of neuro degenerative diseases.

c-Abl–Mediated Tyrosine Phosphorylation of PARP1 Is Crucial for Expression of Proinflammatory Genes

TLDR
It is shown that, in response to LPS or TNF-α exposure, the nonreceptor tyrosine kinase c-Abl undergoes nuclear translocation and interacts with and phosphorylates PARP1 at the conserved Y829 site, and LPS-induced airway lung inflammation was reduced by inhibition of c- abl activity.

Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg.

TLDR
The exploration of the "methylome network" raises the possibility of using SET- and 7β-strand- containing human lysine methyltransferases and their substrates as promising new therapeutic targets for the development of future epigenetic and methyllysine signaling cancer treatments.

Coordination of DNA Base Excision Repair by Protein-Protein Interactions

TLDR
This review focuses on direct interactions of proteins participating in BER with each other and with noncanonical factors found recently to modulate the efficiency of BER.

Coupling of PARP1-mediated chromatin structural changes to transcriptional RNA polymerase II elongation and cotranscriptional splicing

TLDR
These studies suggest a context-specific effect of PARP1–chromatin binding on RNA polymerase movement and provide a platform to delineatePARP1’s role in RNA biogenesis and processing.

References

SHOWING 1-10 OF 37 REFERENCES

Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

TLDR
The total dependence of poly(ADP-ribose) synthesis on DNA strand breaks strongly suggests that this post-translational modification is involved in the metabolism of nucleic acids, and the presence of PARP in these multiprotein complexes clearly supports an important role for poly(ADE-ribosyl)ation reactions in DNA transactions.

Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression

TLDR
PARP3 is described as a newcomer in genome integrity and mitotic progression and a particular role of PARP3 in cellular response to double-strand breaks is reported, most likely in concert with PARP1.

Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase.

TLDR
It is shown that altered phosphorylation at specific sites can modify the dynamics of assembly and disassembly of PARP-1 at sites of DNA damage.

Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

TLDR
Additional functions of PARP-1 are discussed – including regulation of inflammatory mediators, cellular energetics and death pathways, gene transcription, sex hormone- and ERK-mediated signaling, and mitosis – and the role these PARP -1-mediated processes play in oncogenesis, cancer progression, and the development of therapeutic resistance.

On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

TLDR
This review of recent studies in cell and animal models highlights the newest findings about PARP-1's role in stress responses in the context of the historical data.

Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1

TLDR
The results suggest that an increase in CAT protein dynamics underlies the DNA-dependent activation mechanism of PARP-1, and can explain the strong preference for automodification.

Sumoylation of poly(ADP‐ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function

TLDR
Interestingly, modification ofPARP1 with SUMO does not affect its ADP‐ribosylation activity but completely abrogates p300‐mediated acetylation of PARP1, revealing an intriguing crosstalk of sumoylation and acetylations on PARP 1.

Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.

TLDR
The apparent rate constant of mono(ADP- ribosyl)ation in solution indicates that the initiation reaction catalyzed by PARP proceeds 232-fold more slowly than ADP-ribose polymerization.